HEALTH OF WOMAN. 2016.3(109):129–132 
 

The incidence and mortality of breast cancer in women living in the cities of the Republic of Azerbaijan 
 

Mardanly F. A., Vatanha S. S., Aliev F. Yu.

National center of Oncology, Baku 
 

The objective: the aim of this study was to evaluate the incidence and mortality of breast cancer in women living in major cities of the country.

Patients and methods. We analyzed the extensive, intensive and standardized indicators, quantified showing the incidence of breast cancer, designed the overall mortality rate, mortality rate, five-year survival, and prevalence ratio.

Results. In the structure of malignant tumors of breast cancer in the large industrial cities of the country is more than 20.0% (Shirvan – 21.2%, Mingachaur – 22.5%, Sumgait – 25.4%, Ganja – 23.8%). The highest rate of infection among patients with breast cancer was observed in Ganja and amounted to 515,10/0000. Noted high levels of mortality rates in the studied cities of the country (4.2–19.0%). The magnitude of age-standardized incidence rate in the range of 41.70/0000 (Sumgait c.) to 72.80/0000 (Mingechaur c.), with the highest level of this indicator is marked in the age group 50–59 years, the value which ranged from 14.50/0000 (Shirvan c.) to 26.80/0000 (Mingechaur c.).

Conclusion. High incidence of breast cancer in the age group 50–59 years, the value of which was standardized in Sumgait – 16.10/0000, Shirvan с. – 14.50/0000, Mingechaur с. – 26.80/0000, Ganja с. – 18.60/0000.

Key words: breast cancer, the rate of prevalence, morbidity, mortality.

REFERENCES

1. Bilghol R, Bonita R, Kelstrem T. 1994. Osnovyi epidemiologii. VOZ. Zheneva:27–32.

2. Bogatyirev VN. 2009, 10–11 sentyabrya. Znachenie sovremennyih kolichestvennyih metodov issledovaniya v onkologii. Materialyi Rossiyskoy nauchno-prakticheskoy konferentsii s mezhdunarodnyim uchastiem «Sovremennaya onkologiya: dostizheniya i perspektivyi razvitiya», posvyaschennoy 30-letiyu NII onkologii SO RAMN. Tomsk.

3. Gaziev AYu. 2005. Epidemiologiya, meditsinskie, demograficheskie i sotsialno-ekonomicheskie aspektyi zlokachestvennyih novoobrazovaniy v Azerbaydzhane. Avtoref. diss.d-ra med. nauk. Baku:41.

4. Zaridze DG. 2004. Epidemiologiya i etiologiya zlokachestvennyih novoobrazovaniy. Kantserogenez. Pod red. DG Zaridze. M:29–85.

5. Moiseenko VM. 2002. «Estestvennaya istoriya» rosta raka molochnoy zhelezyi. Prakticheskaya onkologiya 3;1:6–14.

6. Fel II, Ahmedov AA, Truman GD. 1973. Metodicheskie ukazaniya k prakticheskim zanyatiyam po meditsinskoy statistike. Baku, Izdanie Meditsinskogo Instituta:76.

7. Chen UI, Uordli E. 2009. Rak molochnoy zhelezyi. M, Rid Elsiver:7.

8. Chissov VI, Starinskiy VV, Petrova GV. 2004. Zlokachestvennyie novoobrazovaniya v Rossii v 2002 godu (zabolevaemost i smertnost). M, MNIOI im. PA Gertsena:256.

9. Ceferov RC, Merdanli FA. 2009. Azerbaycan Respublikasinda sud vezisi xercenginin epidemioloji xususiyyetleri. Hesabat, Baki:17.

10. Parkin D, Whelan S, Ferlay J et all. 1997. Cancer Incidense in Five Continents 7, IARC Scintific Publications 143, IARC, Lyon:240.

11. Stewart B, Kleihues P. 2003. World Cancer Report. IARC Press, Lyon: 351.